Budge James 4

What Happened
James Budge, Chief Financial Officer of Hinge Health, disposed of 781 shares of Class A common stock in an open-market/private sale on May 20, 2026. The shares were sold at $55.34 per share for aggregate proceeds of $43,221. The filing indicates the sale was effected pursuant to a Rule 10b5-1 trading plan.

Key Details

• Transaction date: May 20, 2026; Price: $55.34; Shares sold: 781; Total proceeds: $43,221.
• Footnote: Sale executed under a Rule 10b5-1 plan adopted June 12, 2025.
• Footnote: The 781 shares sold include shares issued to the reporting person on May 15, 2026 under the issuer’s employee stock purchase plan (ESPP).
• Shares owned after transaction: not specified in the information provided on this filing.
• Filing: Form 4 filed May 21, 2026 (next business day), which appears timely.

Context
A Rule 10b5-1 plan allows insiders to schedule trades in advance and is commonly used to avoid timing concerns; sales under such a plan are typically prearranged rather than reactive to recent company developments. The shares sold were recently issued via the company ESPP, which can explain a near-term disposition for routine reasons (e.g., liquidity or tax withholding), but the filing itself does not state the insider’s motivation.